Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cancer vaccine
Biotech
Moderna cancer push 'makes sense' when HHS skeptical of vaccines
Moderna’s efforts to advance its cancer pipeline “make sense” in the current political climate, the company’s oncology chief told Fierce.
James Waldron
Oct 22, 2025 3:00am
BioNTech fades cancer vax in late-stage melanoma setting
Oct 20, 2025 3:01pm
Evaxion stock slips on phase 2 cancer vax data
Oct 17, 2025 2:07pm
TransCode rewrites future, securing $25M and phase 3 vaccine
Oct 8, 2025 11:02am
IO lays off 50% after FDA derails cancer vaccine approval plan
Sep 29, 2025 8:55am
Nykode bets future on cancer trial after losing Genentech pact
Aug 27, 2025 8:25am
